Digital technologies in cancer care: a review from the clinician's perspective
Publication: Journal of Comparative Effectiveness Research
Abstract
Physicians are increasingly utilizing digital health technologies (DHT) such as smartphone applications, network-enabled wearable devices, web-based communication platforms, videoconferencing, chatbots, artificial intelligence and virtual reality to improve access to, and quality of, care. DHT aid in cancer screening, patient education, shared decision-making, promotion of positive health habits, symptom monitoring and intervention, patient–provider communication, provision of psychological support and delivery of effective survivorship care. This narrative review outlines how physicians may utilize digital health to improve or augment their delivery of cancer care. For the full potential of DHT to be realized, experts must develop appropriate solutions to issues surrounding the regulation, liability, quality, security, equity and reimbursement of DHT.
Formats available
You can view the full content in the following formats:
References
1.
US Food and Drug Administration. What is digital health? (2021). www.fda.gov/medical-devices/digital-health-center-excellence/what-digital-health
2.
DeSilva J, Zweig M. 2020 market insights report: chasing a new equilibrium. Rock Health (2020). https://rockhealth.com/insights/2020-market-insights-report-chasing-a-new-equilibrium/
3.
Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Adler NE, Page AEK (Eds). National Academies Press, DC, USA (2008).
4.
Briggs LG, Reitblat C, Bain PA et al. Prehabilitation exercise before urologic cancer surgery: a systematic and interdisciplinary review. Eur. Urol. 81(2), 157–167 (2022).
5.
Garg S, Williams NL, Ip A, Dicker AP. Clinical integration of digital solutions in health care: an overview of the current landscape of digital technologies in cancer care. JCO Clin. Cancer Inform. 2, 1–9 (2018).
6.
Milne-Ives M, de Cock C, Lim E et al. The effectiveness of artificial intelligence conversational agents in health care: systematic review. J. Med. Internet Res. 22(10), e20346 (2020).
7.
Vaidyam AN, Wisniewski H, Halamka JD, Kashavan MS, Torous JB. Chatbots and conversational agents in mental health: a review of the psychiatric landscape. Can. J. Psych. 64(7), 456–464 (2019).
8.
Hong YA, Hossain MM, Chou WS. Digital interventions to facilitate patient-provider communication in cancer care: a systematic review. Psychooncology 29(4), 591–603 (2020).
9.
Charbonneau DH, Hightower S, Katz A et al. Smartphone apps for cancer: a content analysis of the digital health marketplace. Digit. Health 6, 2055207620905413 (2020).
10.
Bibault J-E, Chaix B, Guillemassé A et al. A chatbot versus physicians to provide information for patients with breast cancer: blind, randomized controlled noninferiority trial. J. Med. Internet Res. 21(11), e15787 (2019).
11.
Finnane A, Dallest K, Janda M, Soyer HP. Teledermatology for the diagnosis and management of skin cancer: a systematic review. JAMA Dermatol. 153(3), 319–327 (2017).
12.
Rutan MC, Sammon JD, Nguyen DD, Kilbridge KL, Herzog P, Trinh QD. The relationship between health literacy and nonrecommended cancer screening. Am. J. Prev. Med. 60(2), e69–e72 (2021).
13.
Pucheril D, Dalela D, Sammon J et al. The influence of physician recommendation on prostate-specific antigen screening. Urol. Oncol. 33(10), 424.e1–424.e7 (2015).
14.
Bakouny Z, Paciotti M, Schmidt AL, Lipsitz SR, Choueiri TK, Trinh Q-D. Cancer screening tests and cancer diagnoses during the COVID-19 pandemic. JAMA Oncol. 7(3), 458–460 (2021).
15.
Baptista S, Teles Sampaio E, Heleno B, Azevedo LF, Martins C. Web-based versus usual care and other formats of decision aids to support prostate cancer screening decisions: systematic review and meta-analysis. J. Med. Internet Res. 20(6), e228 (2018).
16.
Johnson DC, Mueller DE, Deal AM et al. Integrating patient preference into treatment decisions for men with prostate cancer at the point of care. J. Urol. 196(6), 1640–1644 (2016).
17.
Ruco A, Dossa F, Tinmouth J et al. Social media and mhealth technology for cancer screening: systematic review and meta-analysis. J. Med. Internet Res. 23(7), e26759 (2021).
18.
Brush K. What is a chatbot? (2021). https://searchcustomerexperience.techtarget.com/definition/chatbot
19.
Owens OL, Felder T, Tavakoli AS et al. Evaluation of a computer-based decision aid for promoting informed prostate cancer screening decisions among African American men: iDecide. Am. J. Health Promot. 33(2), 267–278 (2019).
20.
Heald B, Keel E, Marquard J et al. Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy. J. Med. Genet. 58(12), 807–814 (2020).
21.
Wasserman M, Baxter NN, Rosen B, Burnstein M, Halverson AL. Systematic review of Internet patient information on colorectal cancer surgery. Dis. Colon Rectum 57(1), 64–69 (2014).
22.
Acuna N, Vento I, Alzate-Duque L, Valera P. Harnessing digital videos to promote cancer prevention and education: a systematic review of the literature from 2013–2018. J. Cancer Educ. 35(4), 635–642 (2020).
23.
Salonen A, Ryhänen AM, Leino-Kilpi H. Educational benefits of Internet and computer-based programmes for prostate cancer patients: a systematic review. Patient Educ. Couns. 94(1), 10–19 (2014).
24.
Crawford A, Serhal E. Digital health equity and COVID-19: the innovation curve cannot reinforce the social gradient of health. J. Med. Internet Res. 22(6), e19361 (2020).
25.
Owens OL, Kim S, Tavakoli AS. Are decision aids leading to shared prostate cancer screening decisions among African-American men?: iDecide. Cancer Causes Control 30(7), 713–719 (2019).
26.
National Cancer Institute, U.S. Department of Health & Human Services. Cancer Survivorship: Addressing Complex Needs throughout the Lifespan. National Institutes of Health (2021). www.cancer.gov/research/annual-plan/2022-annual-plan-budget-proposal-aag.pdf#understanding-how-to-improve-the-delivery-of-survivorship-care
27.
Wells M, Aitchison P, Harris F et al. Barriers and facilitators to smoking cessation in a cancer context: a qualitative study of patient, family and professional views. BMC Cancer 17(1), 348 (2017).
28.
Valle CG, Tate DF, Mayer DK, Allicock M, Cai J. A randomized trial of a Facebook-based physical activity intervention for young adult cancer survivors. J. Cancer Surviv. 7(3), 355–368 (2013).
29.
Rabin C, Dunsiger S, Ness KK, Marcus BH. Internet-based physical activity intervention targeting young adult cancer survivors. J. Adolesc. Young Adult Oncol. 1(4), 188–194 (2011).
30.
McCarroll ML, Armbruster S, Pohle-Krauza RJ et al. Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application. Gynecol. Oncol. 137(3), 508–515 (2015).
31.
Nabi J, Cone EB, Vasavada A et al. Mobile health app for prostate cancer patients on androgen deprivation therapy: qualitative usability study. JMIR Mhealth Uhealth 8(11), e20224 (2020).
32.
Valle CG, Deal AM, Tate DF. Preventing weight gain in African American breast cancer survivors using smart scales and activity trackers: a randomized controlled pilot study. J. Cancer Surviv. 11(1), 133–148 (2017).
33.
Mendoza JA, Baker KS, Moreno MA et al. A Fitbit and Facebook mHealth intervention for promoting physical activity among adolescent and young adult childhood cancer survivors: a pilot study. Pediatr. Blood Cancer 64(12), (2017).
34.
Huang JS, Dillon L, Terrones L et al. Fit4Life: a weight loss intervention for children who have survived childhood leukemia. Pediatr. Blood Cancer 61(5), 894–900 (2014).
35.
Sabel M, Sjölund A, Broeren J et al. Active video gaming improves body coordination in survivors of childhood brain tumours. Disabil. Rehabil. 38(21), 2073–2084 (2016).
36.
Chandrasekaran R, Katthula V, Moustakas E. Patterns of use and key predictors for the use of wearable health care devices by US adults: insights from a national survey. J. Med. Internet Res. 22(10), e22443 (2020).
37.
Hoogeboom TJ, Oosting E, Vriezekolk JE et al. Therapeutic validity and effectiveness of preoperative exercise on functional recovery after joint replacement: a systematic review and meta-analysis. PLoS One 7(5), e38031 (2012).
38.
Thomas G, Tahir MR, Bongers BC, Kallen VL, Slooter GD, Van Meeteren NL. Prehabilitation before major intra-abdominal cancer surgery: a systematic review of randomised controlled trials. Eur. J. Anaesthesioly 36(12), 933–945 (2019).
39.
Hedrick TL, Hassinger TE, Myers E et al. Wearable technology in the perioperative period: predicting risk of postoperative complications in patients undergoing elective colorectal surgery. Dis. Colon Rectum 63(4), 538–544 (2020).
40.
Patel Y, Hylton D, Rok M et al. MA16.05 Wearable technology for preconditioning before thoracic surgery: a feasibility study. J. Thoracic Oncol. 14(10), S314 (2019).
41.
Wu JM, Ho TW, Chang YT et al. Wearable-based mobile health app in gastric cancer patients for postoperative physical activity monitoring: focus group study. JMIR Mhealth Uhealth 7(4), e11989 (2019).
42.
Hooke MC, Gilchrist L, Tanner L, Hart N, Withycombe JS. Use of a fitness tracker to promote physical activity in children with acute lymphoblastic leukemia. Pediatr. Blood Cancer 63(4), 684–689 (2016).
43.
Bennett AV, Reeve BB, Basch EM et al. Evaluation of pedometry as a patient-centered outcome in patients undergoing hematopoietic cell transplant (HCT): a comparison of pedometry and patient reports of symptoms, health, and quality of life. Qual. Life Res. 25(3), 535–546 (2016).
44.
Ohri N, Kabarriti R, Bodner WR et al. Continuous activity monitoring during concurrent chemoradiotherapy. Int. J. Radiation Oncol. Biol. Phys. 97(5), 1061–1065 (2017).
45.
Santa Mina D, Hilton WJ, Matthew AG et al. Prehabilitation for radical prostatectomy: a multicentre randomized controlled trial. Surg. Oncol. 27(2), 289–298 (2018).
46.
Zhang X, McClean D, Ko E, Morgan MA, Schmitz K. Exercise among women with ovarian cancer: a feasibility and pre-/post-test exploratory pilot study. Oncol. Nurs. Forum 44(3), 366–374 (2017).
47.
Ruland CM, White T, Stevens M, Fanciullo G, Khilani SM. Effects of a computerized system to support shared decision making in symptom management of cancer patients: preliminary results. J. Am. Med. Inform. Assoc. 10(6), 573–579 (2003).
48.
Pietanza MC, Basch EM, Lash A et al. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. J. Clin. Oncol. 31(16), 2004–2009 (2013).
49.
Basch E, Iasonos A, Barz A et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J. Clin. Oncol. 25(34), 5374–5380 (2007).
50.
Basch E, Deal AM, Kris MG et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J. Clin. Oncol. 34(6), 557–565 (2016).
51.
van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J. Pain Symptom Manage. 51(6), 1070–1090.e9 (2016).
52.
Besse KT, Faber-te Boveldt ND, Janssen GH, Vernooij-Dassen M, Vissers KC, Engels Y. Pain assessment with short message service and interactive voice response in outpatients with cancer and pain: a feasibility study. Pain Pract. 16(3), 320–326 (2016).
53.
Jibb LA, Stevens BJ, Nathan PC et al. Implementation and preliminary effectiveness of a real-time pain management smartphone app for adolescents with cancer: a multicenter pilot clinical study. Pediatr. Blood Cancer 64(10), e26554 (2017).
54.
Di Maio M, Basch E, Bryce J, Perrone F. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat. Rev. Clin. Oncol. 13(5), 319–325 (2016).
55.
Katharine A, Rendle ST. Implementation strategies for monitoring adherence in real time (iSMART). ClinicalTrials.gov NCT04347161. https://clinicaltrials.gov/ct2/show/NCT04347161
56.
Fromme EK, Eilers KM, Mori M, Hsieh Y-C, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J. Clin. Oncol. 22(17), 3485–3490 (2004).
57.
Judson TJ, Bennett AV, Rogak LJ et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J. Clin. Oncol. 31(20), 2580–2585 (2013).
58.
Berry DL, Hong F, Halpenny B et al. The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer 14, 513 (2014).
59.
Baggott C, Gibson F, Coll B, Kletter R, Zeltzer P, Miaskowski C. Initial evaluation of an electronic symptom diary for adolescents with cancer. JMIR Res. Protoc. 1(2), e23 (2012).
60.
Stinson JN, Jibb LA, Nguyen C et al. Development and testing of a multidimensional iPhone pain assessment application for adolescents with cancer. J. Med. Internet Res. 15(3), e51 (2013).
61.
Casillas J, Goyal A, Bryman J et al. Development of a text messaging system to improve receipt of survivorship care in adolescent and young adult survivors of childhood cancer. J. Cancer Surviv. 11(4), 505–516 (2017).
62.
Ruland CM, Andersen T, Jeneson A et al. Effects of an Internet support system to assist cancer patients in reducing symptom distress: a randomized controlled trial. Cancer Nurs. 36(1), 6–17 (2013).
63.
Sansom-Daly U, Wakefield C, McGill BC, Patterson P. Ethical and clinical challenges delivering group-based cognitive-behavioural therapy to adolescents and young adults with cancer using videoconferencing technology. Australian Psychologist 50, 271–278 (2015).
64.
Kroenke K, Theobald D, Wu J et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA 304(2), 163–171 (2010).
65.
Chaix B, Bibault JE, Pienkowski A et al. When chatbots meet patients: one-year prospective study of conversations between patients with breast cancer and a chatbot. JMIR Cancer 5(1), e12856 (2019).
66.
Gershon J, Zimand E, Pickering M, Rothbaum BO, Hodges L. A pilot and feasibility study of virtual reality as a distraction for children with cancer. J. Am. Acad. Child Adolesc. Psych. 43(10), 1243–1249 (2004).
67.
Schneider SM, Prince-Paul M, Allen MJ, Silverman P, Talaba D. Virtual reality as a distraction intervention for women receiving chemotherapy. Oncol. Nurs. Forum 31(1), 81–88 (2004).
68.
Li WH, Chung JO, Ho EK. The effectiveness of therapeutic play, using virtual reality computer games, in promoting the psychological well-being of children hospitalised with cancer. J. Clin. Nurs. 20(15-16), 2135–2143 (2011).
69.
Schover LR, Canada AL, Yuan Y et al. A randomized trial of Internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer 118(2), 500–509 (2012).
70.
Campo RA, Bluth K, Santacroce SJ et al. A mindful self-compassion videoconference intervention for nationally recruited posttreatment young adult cancer survivors: feasibility, acceptability, and psychosocial outcomes. Support. Care Cancer 25(6), 1759–1768 (2017).
71.
Laing CM, Moules NJ, Estefan A, Lang M. Stories that heal: understanding the effects of creating digital stories with pediatric and adolescent/young adult oncology patients. J. Pediatr. Oncol. Nurs. 34(4), 272–282 (2017).
72.
McLaughlin M, Nam Y, Gould J et al. A videosharing social networking intervention for young adult cancer survivors. Comput. Hum. Behav. 28(2), 631–641 (2012).
73.
Greer S, Ramo D, Chang YJ, Fu M, Moskowitz J, Haritatos J. Use of the chatbot “Vivibot” to deliver positive psychology skills and promote well-being among young people after cancer treatment: randomized controlled feasibility trial. JMIR Mhealth Uhealth 7(10), e15018 (2019).
74.
Kunin-Batson A, Steele J, Mertens A, Neglia JP. A randomized controlled pilot trial of a web-based resource to improve cancer knowledge in adolescent and young adult survivors of childhood cancer. Psychooncology 25(11), 1308–1316 (2016).
75.
Kim AR, Park H-A. Web-based self-management support interventions for cancer survivors: a systematic review and meta-analyses. Stud. Health Technol. Inform. 216, 142–147 (2015).
76.
Marzorati C, Renzi C, Russell-Edu SW, Pravettoni G. Telemedicine use among caregivers of cancer patients: systematic review. J. Med. Internet Res. 20(6), e223 (2018).
77.
Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: a meta-analysis. Crit. Rev. Oncol. Hematol. 75(2), 122–137 (2010).
78.
Kimman ML, Bloebaum MM, Dirksen CD, Houben RM, Lambin P, Boersma LJ. Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer 10, 174 (2010).
79.
Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am. Soc. Clin. Oncol. Educ. Book 38, 540–545 (2018).
80.
Sonagli M, Cagnacci Neto R, Leite FPM, Makdissi FBA. The use of telemedicine to maintain breast cancer follow-up and surveillance during the COVID-19 pandemic. J. Surg. Oncol. 123(2), 371–374 (2021).
81.
Chao E, Meenan CK, Ferris LK. Smartphone-based applications for skin monitoring and melanoma detection. Dermatol. Clin. 35(4), 551–557 (2017).
82.
Federal Trade Commission. FTC cracks down on marketers of “melanoma detection” apps (2015). www.ftc.gov/news-events/news/press-releases/2015/02/ftc-cracks-down-marketers-melanoma-detection-apps
83.
US FDA. Policy for device software functions and mobile medical applications (2019). www.fda.gov/media/80958/download
84.
Cortez NG, Cohen IG, Kesselheim AS. FDA regulation of mobile health technologies. N. Engl. J. Med. 371(4), 372–379 (2014).
85.
Anastasiou A, Giokas K, Koutsouris D. Monitoring of compliance on an individual treatment through mobile innovations. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 2015, 7320–7733 (2015).
86.
Nguyen DD, Trinh QD, Cole AP et al. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States. Cancer 127(2), 249–256 (2021).
87.
Font AG. Improving cancer diagnosis and prediction with AI and big data. https://incisive-project.eu/about/ (Accessed 15 September 2021)
88.
Lekadir K. EuCanImage – cancer imaging platform for enhanced Artificial Intelligence in oncology (2021). https://radiomics.bio/eucanimage-project/#:~:text=EuCanImage%20is%20a%204%2Dyear,under%20grant%20agreement%20No%20952103
89.
Lopez-Perez L, Hernández L, Ottaviano M et al. BD2Decide: big data and models for personalized head and neck cancer decision support. Presented at: 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems (CBMS). 67–68 (2019).
90.
European Commission. Predicting effective adaptation to breast cancer to help women to BOUNCE back. https://cordis.europa.eu/project/id/777167 (Accessed 15 September 2021)
91.
Kuijpers W, Groen WG, Aaronson NK, van Harten WH. A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors. J. Med. Internet Res. 15(2), e37 (2013).
92.
Ahmed I, Ahmad NS, Ali S et al. Medication adherence apps: review and content analysis. JMIR Mhealth Uhealth 6(3), e62 (2018).
93.
Gotay CC, Bottomley A. Providing psycho-social support by telephone: what is its potential in cancer patients? Eur. J. Cancer Care (Engl.) 7(4), 225–231 (1998).
Information & Authors
Information
Published In
Pages: 533 - 544
PubMed: 35416050
Copyright
© 2022 Future Medicine Ltd.
History
Received: 23 October 2021
Accepted: 25 March 2022
Published online: 13 April 2022
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Digital technologies in cancer care: a review from the clinician's perspective. (2022) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2021-0263
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Ambre Naeyaert, Valentyn Fournier, Lisa Laroussi-Libeault, Martin Rebillon, Coralie Dubart, Pauline Justin, Christelle Duprez, Pascal Antoine, Carole Haryan, Delphine Grynberg, Kristopher Lamore, A qualitative study on relatives’ perceptions of digital supportive care tools in oncology, European Journal of Oncology Nursing, 10.1016/j.ejon.2026.103280, 84, (103280), (2026).
- Tina Karimaghaie, Genevieve Fasano, Steve Lopez, Samantha Min, Laura Keenahan, Muhammad Danyal Ahsan, Sue Friedman, Emily S. Epstein, Ravi N. Sharaf, Lisa Newman, Melissa K. Frey, Lights genes action: Video strategy for BRCA1/2 patient education, Gynecologic Oncology Reports, 10.1016/j.gore.2026.102157, 66, (102157), (2026).
- Zaklina Tarabar, Elin Børøsund, Sindre H Fosstveit, Sveinung Berntsen, Milada Hagen, Ingvild Vistad, Factors Associated With the Use of the Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology (LETSGO) mHealth App in Routine Follow-Up After Gynecologic Cancer Treatment: Observational Study, JMIR Cancer, 10.2196/89918, 12, (e89918-e89918), (2026).
- Theologia Tsitsi, Giannis Polychronis, Elena Papoui, Constantina Cloconi, Koralia Michail, Andreas Charalambous, Digital health technologies in oncology services: a scoping review of clinical implementation, organisational evidence gaps, and policy implications, Journal of Cancer Policy, 10.1016/j.jcpo.2026.100789, (100789), (2026).
- Victor C Okebalama, Onyebuchukwu Eke, Nwora Oli, Oluyemisi Okwudishu, Obioma Aririsukwu, Cyprian Okoronkwo, Orevaoghene Edewor, Precious Michael, Odutola Odugbemi, Cyril Akwuruoha, David Akwuruoha, Olabiyi Olaniran, Joshua Odeyinka, Christain Ugochukwu, Peace Ogbodo, Chisom Nnadozie, Uzor Victor, The Present and Future Applications of Modern Technologies as Useful Tools in the Management of Cancer: A Narrative Review, Cureus, 10.7759/cureus.109692, (2026).
- Safa Elkefi, Achraf Tounsi, Siwar Boudiche, Alicia K. Matthews, Rose Hernandez, Noureddine Lourimi, Extended reality in supporting cancer patients and survivors: A systematic review on the benefits and challenges across the cancer care continuum, Future Healthcare Journal, 10.1016/j.fhj.2025.100483, 13, 1, (100483), (2026).
- John Bosco Ndinawe, Jerome Kabakyenga, Elizabeth Namukwaya, Edgar Mugema Mulogo, Francisca Nagujja, Identification and mapping of mHealth interventions applied in palliative care in Sub Saharan Africa: a scoping review:, BMC Palliative Care, 10.1186/s12904-026-02034-y, 25, 1, (2026).
- Logan G. Briggs, Sara C. Parke, Vikram S. Gill, Matthew J. Van Ligten, Kelsey L. Beck, Debarshi Sinha, Khalid Y. Alkhatib, Mouneeb M. Choudry, Paul A. Bain, Jaxon Quillen, Christopher A. Dodoo, Phillip Pierorazio, Haidar Abdul‐Muhsin, Paul E. Andrews, Quoc‐Dien Trinh, Sarah P. Psutka, Exercise, nutrition, and psychological support for kidney cancer: a scoping review, BJU International, 10.1111/bju.70134, 137, 4, (579-595), (2026).
- Han‐Wei V. Wu, Ghislaine Jumonville, Melissa P. Beauchemin, Michael E. Roth, Laura C. Pinheiro, Healthcare Utilization and Communication Patterns Among Survivors of Adolescent and Young Adult Cancer: Results From the Health Information National Trends Survey, Pediatric Blood & Cancer, 10.1002/1545-5017.70048, 73, 2, (2025).
- Jacob Tizhe Liberty, Shilni Jacob Liberty, Revolutionizing Mental Healthcare Through AR/VR Technologies, Augmented and Virtual Reality in Immersive Healthcare, 10.1002/9781394302864.ch3, (57-83), (2025).
- See more